ChromaDex Corp (CDXC) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

By Yahoo! Finance | Nov 1, 2024 at 11:06 AM EST

CEO Robert Fried clarified that the $6.4 million improvement in net income was due to changes in working capital. Niagen IV doses are priced at $500-$700 and categorized as pharmaceutical grade sales. The main restraint on clinic growth is the limited supply of Niagen.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.